P&G Hygiene

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 19-Aug, Procter & Gamble Hygiene & Health Care Ltd. is facing a stock price decline to 8,235.00, down 1.0%. This is due to consecutive price drops, poor financial performance, reduced investor participation, and underperformance against benchmarks.

As of 19-Aug, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 8,235.00, which reflects a change of -83.45 (-1.0%). This downward movement can be attributed to several factors highlighted in the source data. <BR><BR>Firstly, the stock has been on a consecutive decline for the past four days, with a total drop of -3% during this period. Additionally, it has underperformed its sector by -0.45% today. The stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend.<BR><BR>Moreover, the stock has reached a new 52-week low of Rs. 8232.05 today, which further signifies a lack of investor confidence. The delivery volume has also decreased significantly, falling by -20.93% compared to the 5-day average, suggesting a decline in investor participation.<BR><BR>Financially, the company has shown poor long-term growth, with net sales growing at an annual rate of only 3.50% and operating profit at 4.39% over the last five years. Recent quarterly results have been disappointing, with a significant drop in profit after tax (PAT) by -34.3% and net sales hitting their lowest at Rs. 891.46 crore. <BR><BR>Despite having a high return on equity (ROE) of 82.27% and being net-debt free, the stock's valuation appears expensive with a price-to-book value of 35.5, which may deter potential investors. Furthermore, the stock has consistently underperformed against the benchmark indices, generating a return of -38.06% over the past year, which is significantly worse than the -5.80% return of the benchmark.<BR><BR>In summary, the combination of consecutive price declines, poor financial performance, reduced investor participation, and consistent underperformance against benchmarks are key reasons for the falling stock price of Procter & Gamble Hygiene & Health Care Ltd.

Which are the latest news on P&G Hygiene?

Who are in the management team of P&G Hygiene?

The management team of P&G Hygiene includes A K Gupta, Sonali Dhawan, Karthik Natarajan, Pramod Agarwal, Gagan Sawhney, Meena Ganesh, Ghanashyam Hedge, Chittranjan Dua, Krishnamurthy Narayanan Iyer, L. V. Vaidyanathan, and Gurcharan Das, offering a diverse range of expertise and leadership.

The management team of P&G Hygiene includes the following individuals:<BR><BR>1. A K Gupta - Independent Director<BR>2. Sonali Dhawan - Director<BR>3. Karthik Natarajan - Director<BR>4. Pramod Agarwal - Director<BR>5. Gagan Sawhney - Director<BR>6. Meena Ganesh - Independent Director<BR>7. Ghanashyam Hedge - Executive Director & Secretary<BR>8. Chittranjan Dua - Chairman & Independent Director<BR>9. Krishnamurthy Narayanan Iyer - Independent Director<BR>10. L. V. Vaidyanathan - Managing Director<BR>11. Gurcharan Das - Independent Director<BR><BR>This team brings a diverse range of expertise and leadership to the company.

What does P&G Hygiene do?

Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) manufactures and sells branded fast-moving consumer goods in the femcare and healthcare sectors, with a market cap of INR 27,502 Cr and a net profit of 126 Cr for the quarter ending June 2026. Key metrics include a P/E ratio of 35.00 and a dividend yield of 3.08%.

Overview:<BR>Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare sectors, operating within the FMCG industry and categorized as a mid-cap company.<BR><BR>History:<BR>P&GHHCL was incorporated in an unspecified year and has maintained its status as a key player in the FMCG sector. The latest quarterly results reported net sales and net profit for the period ending June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 890 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: 126 Cr (Quarterly Results - Jun 2026)<BR>- Market Cap: INR 27,502 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 35.00<BR>- Industry P/E: 45<BR>- Dividend Yield: 3.08%<BR>- Debt Equity: -0.75<BR>- Return on Equity: 104.94%<BR>- Price to Book: 36.40<BR><BR>Contact Details:<BR>- Address: P & G Plaza Chakala, Cardinal Gracias Rd Andheri(E) Mumbai Maharashtra : 400099<BR>- Tel: 91-22-28266000<BR>- Email: investorpghh.i@pg.com<BR>- Website: http://www.in.pg.com

Who are the peers of the P&G Hygiene?

P&G Hygiene's peers include Godrej Consumer, Dabur India, Colgate-Palmoliv, Cupid, Godfrey Phillips, Gillette India, Hatsun Agro, Emami, and Zydus Wellness. P&G Hygiene has below-average growth and the lowest 1-year return at -35.21% among its peers.

Peers: The peers of P&G Hygiene are Godrej Consumer, Dabur India, Colgate-Palmoliv, Cupid, Godfrey Phillips, Gillette India, Hatsun Agro, Emami, and Zydus Wellness.<BR><BR>Quality Snapshot: Excellent management risk is observed at Colgate-Palmoliv, Godfrey Phillips, Gillette India, Emami, and P&G Hygiene, while Good management risk is found at Godrej Consumer and Hatsun Agro, and Average management risk is present at Cupid and Zydus Wellness. Growth is rated as Good for Cupid, while Below Average growth is seen in Godrej Consumer, Dabur India, Colgate-Palmoliv, Gillette India, Emami, and P&G Hygiene, with the rest showing Below Average growth as well. Capital Structure is rated as Excellent for Godrej Consumer, Dabur India, Colgate-Palmoliv, Cupid, Godfrey Phillips, P&G Hygiene, Gillette India, Emami, and Zydus Wellness, while Hatsun Agro has an Average capital structure.<BR><BR>Return Snapshot: Cupid has the highest 1-year return at 779.25%, while P&G Hygiene has the lowest at -35.21%, indicating a significantly poorer performance compared to its peers. Additionally, Godfrey Phillips, P&G Hygiene, Gillette India, Emami, and Dabur India all have negative six-month returns.

How big is P&G Hygiene?

As of 14th August, Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 27,331.94 Cr, with recent net sales of 4,236.35 Cr and a net profit of 790.72 Cr over the latest four quarters.

As of 14th August, <BR><BR>Market Cap: Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 27,331.94 Cr, classified as a Mid Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 4,236.35 Cr, while the sum of Net Profit for the same period is 790.72 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 736.99 Cr, and Total Assets amount to 1,672.31 Cr.

Are Procter & Gamble Hygiene & Health Care Ltd. latest results good or bad?

Procter & Gamble Hygiene & Health Care Ltd.'s latest results are concerning, with a 34.27% decline in net profit and a 4.84% drop in revenue year-on-year, indicating significant operational challenges and declining profitability. The operating margin has also contracted sharply, reflecting increased competitive pressures.

The latest results for Procter & Gamble Hygiene & Health Care Ltd. are concerning. In the first quarter of FY27, the company reported a net profit of ₹126.27 crores, which represents a significant decline of 34.27% compared to the same quarter last year. Revenue also fell by 4.84% year-on-year, totaling ₹889.92 crores, marking the lowest quarterly revenue recorded in recent periods.<BR><BR>Additionally, the operating margin has contracted sharply to 19.11%, down from 28.46% in the previous year, indicating increased competitive pressures and potential pricing challenges. The profit after tax margin also decreased to 14.19%, down from 20.54% a year ago.<BR><BR>Overall, these results reflect a troubling trend of declining profitability and revenue, suggesting that the company is facing significant operational challenges. The combination of reduced sales, margin compression, and a negative financial trend points to a difficult environment for Procter & Gamble Hygiene & Health Care Ltd. at this time.

Should I buy, sell or hold Procter & Gamble Hygiene & Health Care Ltd.?

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share), with an ex-date of February 5, 2026. Despite the significant dividend, total returns have been negative over shorter periods, improving in the long term.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: 05 Feb 26<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the 6-month period, the price return was -14.1%, the dividend return was 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over the 2-year period, the price return was -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>During the 4-year period, the price return was -17.88%, the dividend return was 3.91%, culminating in a total return of -13.97%.<BR><BR>In the 5-year period, the price return was 5.2%, the dividend return was 7.14%, resulting in a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a trend of negative performance, particularly in the shorter time frames, with a more favorable outcome in the longer term.

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share) with an ex-date of August 28, 2025. Despite this, the company has experienced negative total returns over the past 1 to 4 years, though it showed a positive return of 12.34% over the last 5 years.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: Aug-28-2025<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>Over the past 3 months, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the last 6 months, the price return decreased by -14.1%, with a dividend return of 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over 2 years, the price return fell by -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>For the 4-year period, the price return decreased by -17.88%, with a dividend return of 3.91%, resulting in a total return of -13.97%.<BR><BR>In the 5-year span, the price return increased by 5.2%, the dividend return was 7.14%, leading to a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a challenging performance, particularly in the shorter terms, with negative returns dominating. However, the 5-year period shows a positive total return, suggesting potential recovery or growth in the long term.

How has been the historical performance of P&G Hygiene?

P&G Hygiene has shown consistent growth in net sales, reaching 4,191.57 Cr in June 2024, but experienced a slight decline in profit after tax and cash flow from operating activities. Total assets and liabilities decreased, indicating potential restructuring despite strong sales performance.

Answer:<BR>The historical performance of P&G Hygiene shows a consistent upward trend in net sales and operating profit over the years, with net sales reaching 4,191.57 Cr in June 2024, up from 3,905.21 Cr in June 2023 and 3,792.45 Cr in June 2022. Operating profit also increased to 1,022.69 Cr in June 2024 from 909.21 Cr in June 2023. However, profit after tax saw a slight decline to 675.02 Cr in June 2024 from 678.14 Cr in June 2023. The company's total assets decreased to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023, while total liabilities also fell to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023. Cash flow from operating activities decreased to 470.00 Cr in June 2024 from 825.00 Cr in June 2023, indicating a tightening in cash generation.<BR><BR>Breakdown:<BR>P&G Hygiene has demonstrated a robust growth trajectory in net sales, which climbed from 3,001.99 Cr in June 2020 to 4,191.57 Cr in June 2024, reflecting a strong demand for its products. Operating profit, excluding other income, also showed a positive trend, increasing from 603.71 Cr in June 2020 to 970.44 Cr in June 2024, although the profit after tax slightly declined in the latest fiscal year. The company's total assets and liabilities both decreased in June 2024 compared to the previous year, suggesting a potential restructuring or reduction in operational scale. Furthermore, cash flow from operating activities has seen a decline, which may indicate challenges in maintaining liquidity despite the growth in sales and profits. Overall, while P&G Hygiene has achieved significant sales growth, the fluctuations in profit margins and cash flow warrant close monitoring.

Is P&G Hygiene technically bullish or bearish?

As of November 3, 2025, P&G Hygiene's trend is mildly bearish, influenced by daily moving averages and monthly MACD signals, despite some mildly bullish indicators on the weekly MACD.

As of 3 November 2025, the technical trend for P&G Hygiene has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating bearish momentum and the monthly MACD showing a bearish signal. The weekly MACD is mildly bullish, but this is offset by the monthly Bollinger Bands and KST both indicating bearish conditions. The RSI shows no signal in both weekly and monthly time frames, suggesting a lack of strong momentum in either direction. Overall, the mixed signals across different indicators reflect a weak bearish sentiment.

Who are the top shareholders of the P&G Hygiene?

The top shareholder of P&G Hygiene is Procter And Gamble Overseas India B.V. with 68.73%. Other significant shareholders include mutual funds at 8.26%, individual investors at 9.76%, and Foreign Institutional Investors at 1.33%.

The top shareholders of P&G Hygiene include Procter And Gamble Overseas India B.V., which holds the largest stake at 68.73%. Additionally, mutual funds collectively hold 8.26% through 15 schemes, with the SBI Focused Equity Fund being the highest public shareholder at 5.73%. Foreign Institutional Investors (FIIs) hold 1.33% through 108 entities, while individual investors account for 9.76% of the shareholding. There are no pledged promoter holdings reported.

When is the next results date for P&G Hygiene?

No Upcoming Board Meetings